Annie L. Conery

Massachusetts General Hospital

Papers

3

Total Citations

342

H-Index

3

About

Annie L. Conery is a pioneering researcher at the intersection of antimicrobial drug discovery, high-throughput screening, and *Caenorhabditis elegans* biology. Her work has been instrumental in establishing the nematode *C. elegans* as a powerful whole-animal model system for identifying novel therapeutic compounds against dangerous human pathogens. Conery's landmark 2009 study on high-throughput screening for antimicrobials using *C. elegans* infected with *Enterococcus faecalis* garnered over 210 citations, demonstrating the model's remarkable utility for discovering in vivo anti-infective agents. Building on this foundation, her 2014 research extended the platform to combat multi-drug resistant *Staphylococcus aureus* — the leading cause of hospital-acquired infections in the United States — earning nearly 100 citations and reflecting the urgent clinical relevance of her work. Conery has also made significant methodological contributions, developing probabilistic shape models to resolve clustered worm images in automated microscopy pipelines, advancing the computational infrastructure that makes large-scale *C. elegans* screening feasible. Together, her contributions have helped transform whole-animal drug discovery into a scalable, automated discipline with real-world implications for combating antibiotic resistance.

Research Focus

Key Achievements

3
H-Index
3
Papers
342
Total Citations
114
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Screen for Novel Antimicrobials using a Whole Animal Infection Model
210 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Massachusetts General Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago